iiinova — where your digital self keeps evolving

Journal of Cardiac Failure @jcardfail.bsky.social · 06/10/2026

📝 Editorial perspective: Instead of refining exceptions, should we redefine medical urgency? Continuous distribution could better differentiate risk and reduce manipulation. An opportunity to rethink the rules. Not the exceptions.🫀 🔗 bit.ly/3SQqiJG

000

Journal of Cardiac Failure @jcardfail.bsky.social · 06/10/2026

🫀Status 1 listings doubled after the 2018 allocation change, driven by exceptions now comprising >50% of Status 1. Exception use varied widely, and these candidates had lower risk of death/deterioration than standard Status 1 candidates. 🔗 bit.ly/4xftXPg

100

Journal of Cardiac Failure @jcardfail.bsky.social · 01/10/2026

CON: Conversely, Dr. Kelly Schlendorf argues that the complications of LVAD are not trivial and include bleeding, allosensitization, deconditioning, adhesive disease/unfavorable surgical anatomy, and poor quality of life. 🔗 bit.ly/4ifYQze

000

Journal of Cardiac Failure @jcardfail.bsky.social · 01/10/2026

Dr. Nir Uriel et al support an LVAD-first approach, citing an extended therapeutic timeline, reduction in early (waitlist) mortality, possibility of myocardial recovery & finite lifespan of transplant allografts as key factors. 🔗 bit.ly/3Tjqhhu

100

Journal of Cardiac Failure @jcardfail.bsky.social · 01/10/2026

In young heart transplant candidates, is it best to pursue an LVAD-first approach or proceed directly to transplant? This JCF Focus Issue offers a debate, with perspective pieces for and against an LVAD-first approach.

100

Journal of Cardiac Failure @jcardfail.bsky.social · 23/09/2026

🫀 Donor heart preservation is moving beyond the ice box. From controlled hypothermia & ex-vivo perfusion to HOPE and 10°C storage, this State-of-the-Art review explores technologies poised to expand donor utilization and reshape heart transplantation. 🔗 bit.ly/4iUVj9L

000

Journal of Cardiac Failure @jcardfail.bsky.social · 22/09/2026

📝Editorial perspective: The DCD juggernaut continues! As DCD moves from innovation to infrastructure, success must be measured beyond outcomes. Ethical stewardship, transparency, cost-effectiveness & preservation of public trust are critical to its future. 🔗 bit.ly/3SUAIIc

000

Journal of Cardiac Failure @jcardfail.bsky.social · 22/09/2026

🚨New Science Alert! 🫀DCD heart transplantation has expanded rapidly nationwide to more centers & higher-risk recipients. Yet graft failure, mortality & other early outcomes remained stable. This UNOS analysis supports the robustness & scalability of DCD. 🔗 bit.ly/3SOqgSx

100

Journal of Cardiac Failure @jcardfail.bsky.social · 17/09/2026

🫀Does heart allocation measure how sick a patient is, or what treatment they receive? This State-of-the-Art review examines the unintended consequences of therapy-based status tiers & makes the case for continuous, objective measures of medical urgency. 🔗 bit.ly/4iRCqo7

000

Journal of Cardiac Failure @jcardfail.bsky.social · 15/09/2026

📝 Editorial perspective: Structural objectivity ≠ moral objectivity. Clear allocation rules make value judgments visible. They don't eliminate them. The next challenge: designing systems that reduce waitlist mortality, improve equity & sustain public trust.🫀 🔗 bit.ly/3SY4mMx

020

Journal of Cardiac Failure @jcardfail.bsky.social · 15/09/2026

🌍How do countries decide who gets a donor heart first? This research article analyzes heart allocation policies globally. Across 29 countries, 93% of allocation systems use urgency tiers. But how urgency, MCS priority, & exceptions are defined varies widely. 🔗 bit.ly/4xN1bXq

111

Journal of Cardiac Failure @jcardfail.bsky.social · 14/09/2026

⏰Final Call Submissions for JCF's Focus Issue: The New Frontier of Heart Function in Women close soon. If your research advances women's cardiovascular health, now's the time to submit. 📅Submissions close 9/15/26 bit.ly/4xQkPSR #WomensHeartHealth #CallForPapers

000

Journal of Cardiac Failure @jcardfail.bsky.social · 10/09/2026

💥Could we incentivize cardiac recovery without jeopardizing transplant access? A proposed “Safety Net” would let selected patients pursue LVAD+GDMT for recovery while preserving elevated Tx status if recovery fails. Could this decongest the waitlist?🫀 🔗 bit.ly/4zoKmmJ

000

Journal of Cardiac Failure @jcardfail.bsky.social · 09/09/2026

And the evolution continues after transplant: noninvasive rejection surveillance, precision immunosuppression, and greater focus on long-term allograft survival. And on the horizon: xenotransplantation. 🔬🫀 A must-read article!

000

Journal of Cardiac Failure @jcardfail.bsky.social · 09/09/2026

🫀 Heart transplantation is entering a new era! This State-of-the-Art review explores advances reshaping the field: individualized LVAD vs transplant decisions, DCD & HCV+ donors, and new organ preservation strategies expanding the donor pool. 🔗 bit.ly/45xVQXm 🧵👇

110

Journal of Cardiac Failure @jcardfail.bsky.social · 09/09/2026

What's next in heart transplantation? 🫀 Find out in the September Focus Issue on Innovations in Heart Transplantation. Explore research and perspectives on new developments advancing heart transplantation care. 🔗 onlinejcf.com/current #HeartTransplantation #Cardiology

000

Journal of Cardiac Failure @jcardfail.bsky.social · 08/09/2026

📝 Editorial perspective Discordance between PAWP and LVEDP shouldn't simply lead us to discount LVEDP. Instead, the pressure difference may offer important clues to underlying pathology affecting left atrial function. 🫀 🔗 bit.ly/4ibdM1p

010

Journal of Cardiac Failure @jcardfail.bsky.social · 08/09/2026

🚨New science alert! PAWP or LVEDP ... which better predicts outcomes? Using simultaneous invasive hemodynamics at rest & during exercise, this study found that PAWP better reflected hemodynamic abnormalities & predicted adverse HF outcomes. 🫀 🔗 bit.ly/4x64Z5K

110

Journal of Cardiac Failure @jcardfail.bsky.social · 03/09/2026

⏳ The deadline is approaching. JCF is still accepting submissions for the upcoming Focus Issue: The New Frontier of Heart Function in Women. If your research advances women's cardiovascular health, we encourage you to submit by 9/15/26. bit.ly/4xQkPSR #WomensHeartHealth #CallForPapers

000

Journal of Cardiac Failure @jcardfail.bsky.social · 02/09/2026

🧬 Precision medicine begins with a diagnosis. In the largest real-world study to date, only 1.05% of patients with cardiomyopathy underwent genetic testing and just 7% received genetic counseling. Implementation — not evidence — remains the challenge. 🔗 bit.ly/4qpMbvF

011

Journal of Cardiac Failure @jcardfail.bsky.social · 27/08/2026

📝 Editorial perspective DCD heart transplantation shouldn't be limited to high-volume centers. With standardized procurement, appropriate infrastructure & shared expertise, broader adoption could reduce geographic disparities & improve access. 🫀 🔗 bit.ly/4658cGz

000

Journal of Cardiac Failure @jcardfail.bsky.social · 27/08/2026

🫀Does transplant center volume influence DCD heart transplant outcomes? This UNOS analysis found similar perioperative outcomes and short-term survival at high & low-volume centers, supporting the growing robustness & reproducibility of DCD transplantation. 🔗 bit.ly/3U4HUl9

100

Journal of Cardiac Failure @jcardfail.bsky.social · 26/08/2026

Women's cardiovascular health deserves research that reflects their experiences. Submit to JCF's Focus Issue: The New Frontier of Heart Function in Women. 📅 Submit by 9/15/26 bit.ly/4xQkPSR #WomensHeartHealth #CallForPapers

000

Journal of Cardiac Failure @jcardfail.bsky.social · 25/08/2026

🫀Is predicted heart mass still the best way to size-match donor hearts? This Perspective questions PHM in the modern era, highlighting its limitations in obesity & calling for next-generation metrics that better reflect body composition & cardiac size. 🔗 bit.ly/45xRZtm

001

Journal of Cardiac Failure @jcardfail.bsky.social · 20/08/2026

📝 Editorial perspective The question isn't whether OOS heart tx should expand or disappear. It's how to give it structured legitimacy. Standardized criteria, transparency, and better data will be key to ensuring equitable organ allocation. 🫀 🔗 bit.ly/462hfbo

001

Journal of Cardiac Failure @jcardfail.bsky.social · 20/08/2026

🫀Out-of-sequence heart transplantation remains uncommon. But it's growing. This study found OOS allocation increased from 1.4% to 3.1%, was concentrated in a small number of OPOs & centers, & achieved similar 1-year survival to standard allocation. 🔗 bit.ly/4qhMFDS

101

Journal of Cardiac Failure @jcardfail.bsky.social · 18/08/2026

Out now! The August issue of JCF is live. Catch up on the latest research and insights in heart failure. See what’s inside 👉 onlinejcf.com/current #HeartFailure #Cardiology #HeartFailureResearch

000

Journal of Cardiac Failure @jcardfail.bsky.social · 11/08/2026

The future of women's cardiovascular care starts with today's research. Submit your work to JCF's Focus Issue: The New Frontier of Heart Function in Women. 📅 Deadline: 9/15/26 bit.ly/4xQkPSR #WomensHeartHealth #CallForPapers

000

Journal of Cardiac Failure @jcardfail.bsky.social · 06/08/2026

How reliable is urine sodium concentration during continuous IV diuresis? This Brief Report found substantial temporal variability in urine sodium despite stable loop diuretic infusions, raising questions about its role in monitoring diuretic response. 🔗 bit.ly/4wKoG2A

010

Journal of Cardiac Failure @jcardfail.bsky.social · 05/08/2026

📝 Editorial perspective As LVAD technology improves, the role of adjunctive aspirin may be changing. Modern HM3 LVAD support may allow simpler antithrombotic strategies with less bleeding and no loss of efficacy. 🫀 🔗 bit.ly/3TGod2X

001

Journal of Cardiac Failure @jcardfail.bsky.social · 05/08/2026

New science alert! Do AF, diabetes, or obesity change the benefits of aspirin withdrawal after HM3 LVAD?💖 This ARIES-HM3 analysis says no. Bleeding decreased without increases in stroke or thrombosis, even in these higher-risk subgroups.🩸 🔗 bit.ly/4gbLxhI

100

Journal of Cardiac Failure @jcardfail.bsky.social · 04/08/2026

Hear from the guest editors leading The New Frontier of Heart Function in Women as they share their excitement for this upcoming focus issue. 📅 Submissions open through Sept. 15th: bit.ly/4fC1NZh #WomensHeartHealth #HeartFailure #CallForPapers

000

Journal of Cardiac Failure @jcardfail.bsky.social · 30/07/2026

🫀🤖 Digital twins may help transform HF care from reactive to anticipatory! This JCF Perspectives article explores how patient-specific computational models or "digital twins" could enable earlier detection of instability and more personalized care. 🔗 bit.ly/3TMBHKp

010

Journal of Cardiac Failure @jcardfail.bsky.social · 28/07/2026

Editorial perspective: Only 0.2% of hospitalized HF patients carried an ATTR-CM diagnosis. Diagnosed patients may represent just the tip of the iceberg.🧊 Earlier detection of subclinical disease could reshape outcomes and healthcare utilization.🫀 🔗 bit.ly/3S2tq4y

000

Journal of Cardiac Failure @jcardfail.bsky.social · 28/07/2026

How great is the burden of ATTR-CM? 🫀 In this study using the GWTG-HF registry, patients with ATTR-CM had higher HF readmission rates and greater healthcare costs, despite similar adjusted mortality. Earlier diagnosis and treatment remain critical! 🔗 bit.ly/3RhHBCH

100

Journal of Cardiac Failure @jcardfail.bsky.social · 23/07/2026

Can interatrial shunts help HFpEF? This State-of-the-Art Review revisits atrial shunt therapy, highlighting how phenotyping, invasive exercise hemodynamics & pulmonary vascular assessment may identify responders while avoiding harm in nonresponders. 🔗 bit.ly/45pzqY5

000

Journal of Cardiac Failure @jcardfail.bsky.social · 22/07/2026

Call for Papers 📃 JCF invites research examining cardiovascular health from adolescence through healthy aging for our upcoming Focus Issue: The New Frontier of Heart Function in Women. 📅 Deadline: 9/15/26 bit.ly/4xQkPSR #WomensHeartHealth #CallForPapers

000

Journal of Cardiac Failure @jcardfail.bsky.social · 21/07/2026

⭐️Editorial perspective: Can implantable IVC sensing transform HF care?❤️ The NORM Score may enable earlier congestion detection, patient self-management & proactive intervention. Success will depend on validation, implementation, pt selection & stakeholder buy-in. bit.ly/4frdd0m

011

Journal of Cardiac Failure @jcardfail.bsky.social · 21/07/2026

Can we detect worsening HF before symptoms develop?📡❤️ A novel personalized congestion score derived from an IVC sensor predicted worsening HF events w/92.6% sensitivity & correlated with NT-proBNP levels. Early detection may enable more proactive HF management. bit.ly/44HJTOp

100

Journal of Cardiac Failure @jcardfail.bsky.social · 16/07/2026

Sleep apnea & HFpEF have a bidirectional relationship.💤❤️ Shared mechanisms - intermittent hypoxia, inflammation, sympathetic activation & HTN - may contribute to worse remodeling & outcomes. The editorial calls for routine screening & earlier treatment.💡 🔗 onlinejcf.com/article/S107...

000

Journal of Cardiac Failure @jcardfail.bsky.social · 16/07/2026

Could sleep apnea be a key driver of adverse outcomes in HFpEF?❤️‍🩹 In a PARAGON-HF analysis, patients with SA had greater LV remodeling, worse BiV strain & 57% ⬆️ risk of HFH or CV death. SA may represent an important, modifiable HFpEF phenotype. onlinejcf.com/article/S107...

100

Journal of Cardiac Failure @jcardfail.bsky.social · 15/07/2026

Editorial perspective📝 Quadruple GDMT remains underutilized. Even when achieved, substantial residual risk persists. Drs Greene & Butler argue that vericiguat's safety, tolerability & ease of use make it an attractive option as part of "quintuple therapy". 🔗 onlinejcf.com/article/S107...

000

Journal of Cardiac Failure @jcardfail.bsky.social · 15/07/2026

How is vericiguat being used in real-world HFrEF care? ❤️‍ In a study of >5,100 US patients following a worsening HF event, only ~36% reached the target 10 mg dose. Patients already receiving robust GDMT were more likely to achieve target dosing. 💊📊 🔗 onlinejcf.com/article/S107...

100

Journal of Cardiac Failure @jcardfail.bsky.social · 14/07/2026

🫀 The July edition of JCF is here! Featuring the latest perspectives and studies on heart failure and patient care. 🔗 Read the full issue: onlinejcf.com/current

000

Journal of Cardiac Failure @jcardfail.bsky.social · 09/07/2026

📣 Call for Papers JCF is accepting submissions for our focus issue: The New Frontier of Heart Function in Women Research spanning the female lifespan, from reproductive health to HFpEF, prevention, and heart failure is encouraged. 📅 Submit by 9/15/26 bit.ly/4xQkPSR #WomensHeartHealth

110

Journal of Cardiac Failure @jcardfail.bsky.social · 08/07/2026

Can LVADs do more than support circulation? 🫀 This JCF Ignite! article explores whether LVAD-mediated unloading can promote reverse remodeling and myocardial recovery, and whether some patients might benefit from LVAD therapy as a bridge to regeneration. ❤️‍🩹 🔗 bit.ly/3S0UHEj

000

Journal of Cardiac Failure @jcardfail.bsky.social · 07/07/2026

Editorial perspective 📝: Palliative care is not just end-of-life care. This editorial argues for integrating symptom management, shared decision-making & GoC discussions earlier in advanced HF, making palliative care a core component of longitudinal HF care. 💙 🔗 bit.ly/4oltKXL

000

Journal of Cardiac Failure @jcardfail.bsky.social · 07/07/2026

How should palliative care fit into advanced HF care? 💙 The HeartPal program embedded palliative care directly within an advanced heart disease service, resulting in earlier referrals, more GoC discussions, fewer late referrals & reduced in-hospital deaths. 🫀 🔗 bit.ly/3S4btlS

100

Journal of Cardiac Failure @jcardfail.bsky.social · 02/07/2026

🚨HF-CS is now more common than AMI-CS. This State-of-the-Art Review examines how microaxial flow pumps are reshaping HF-CS care through LV unloading, prolonged support, hemodynamic-guided management, and bridge-to-recovery/transplant strategies. 🫀📊 🔗 bit.ly/4ez3oye

000

Journal of Cardiac Failure @jcardfail.bsky.social · 01/07/2026

🚨 What is the optimal MAP target in AMI-CS? This meta-analysis found no mortality benefit with higher MAP targets vs lower targets. 📊 The findings challenge a "higher is better" approach & highlight the need for individualized perfusion goals. ❤️‍🩹 🔗 bit.ly/4vL6dSW

000